A novel apatite-wollastonite/poly(lactic acid) (AW/PLA) composite structure, which matches cortical and cancellous bone properties has been produced and evaluated in vitro and in vivo. The composites structure has been produced using an innovative combination of 3D printed polymer and ceramic macrostructures, thermally bonded to create a hybrid composite structure. In vitro cell assays demonstrated that the AW structure alone, PLA structure alone, and AW/PLA composite were all biocompatible, with the AW structure supporting the proliferation and osteogenic differentiation of rat bone marrow stromal cells.
Introduction
The varying mechanical properties of bone throughout its volume means that it is difficult for a synthetic implant formed from a single material to match the anisotropic properties in different regions. Furthermore, discrete anatomical regions such as cortical, sub-chondral and cancellous bone each have their own unique mechanical properties and architectures (Keaveny and Hayes, 1993; Li and Aspden, 1997) . Ceramic-polymer composites have been proposed as bone implants most commonly as particulate reinforced polymer structures (Rezwan et al., 2006) , either solid or porous. This produces a material which has the strength of the polymer phase, and a slightly higher modulus than the polymer phase, which for most resorbable biopolymers is normally a good match to the mechanical properties of cancellous bone (Rezwan et al., 2006) . The mechanical response of an implant can also be varied through design of the structure and in recent years various additive manufacturing techniques have been used, along with other techniques, to create macro-porous structures in metals, polymer and ceramic materials (Mota et al., 2015; Wang et al., 2016) , again potentially allowing properties to be matched to different regions of bone. However, the wide range of variation in properties of natural bone is such that they may be better reproduced by bringing together two distinct structures made from two different biomaterials.
The aim of the study reported here was to evaluate the potential for porous ceramic-polymer composites in bone implants, with the different constituent parts of the composite engineered to have properties which equate to both cortical and cancellous bone. The two phases of the composite were a macroporous poly(lactic acid) (PLA) structure, with mechanical properties which match those of cancellous bone (Rodrigues et al., 2016) , together with microporous apatite-wollastonite glass-ceramic (AW), with mechanical properties which approach those of cortical bone (Mancuso et al., 2017) . PLA and AW are both recognised biomaterials (Narayanan et al., 2016; Kokubo, 1991) , with established methods for processing them to create porous structures. The overall approach adopted was to create the individual structures and a macro-scale composite which combined the two structures, and to evaluate these in vitro and in vivo to determine the value that the approach might offer in terms of the design of structural composite implants.
Materials and Methods

Raw Materials
AW frit and powders were produced to a formulation originally proposed by Kokubo (1991) : weight% 4.6 MgO, 44.7 CaO, 34 SiO2, 16 .2 P2O5 and 0.5 CaF2. Maltodextrin (MD) powder (99.5% purity) was purchased from Oneon (Bristol, UK). The AW and maltodextrin powders were separately ground and sieved, and then mixed to create a powder blend which was 55 wt% AW powder with particle sizes in the 54-90 µm range, 15 wt% AW powder with particle sizes in the 0-53 µm range, and 30% MD powder with particle sizes in the 0-53 µm range.
A 3 mm nominal diameter PLA filament (4032D, Nature Works®) with an L-lactide: D-lactide ratio of 98:2 and a density of 1.24 g/cm 3 was the material used to create the porous polymer structure.
Indirect 3D Printing of AW
The indirect 3D printing processing route was to use a ZPrinter 310 Plus 3D printer (ZCorp, USA) to produce a green part, which was then sintered in a furnace (Carbolite, Germany).
The manufacturing process is described in Mancuso et al. (2016) . In brief, to produce the green part the AW/MD powder blend was loaded into the printer, and the zb®60 clear binder (ZCorp) jetted to sequentially bind together layers of powder. The ZPrinter machine settings were: layer thickness 0.1 mm; bleed compensation off; shell saturation level 100%; shell binder/volume ratio 0.215; core saturation level 100%; and core binder/volume ratio 0.107.
The green parts created were disks of nominal diameter of 10.25 mm, and nominal heights of 1.13 or 2.25 mm. The green parts were sintered according to a sintering cycle originally developed by Xiao et al. (2008) . From room temperature the temperature was raised at 10ºC/min to 779ºC, the temperature was then held at 779ºC for 1 hour before the temperature was raised to 1150ºC at 10ºC/min, where the temperature was held constant for 1 h, after which the disks were cooled to room temperature at the natural rate of the furnace.
AW disks were sterilised in a steam autoclave at 121ºC for 15 mins.
Fused Filament Fabrication of PLA Structures
For the PLA structure fabrication a 2-step manufacturing route described by Rodrigues et al. (2016) was used. Briefly the first step consisted of printing PLA rectangular porous bars with a nominal length or 184 mm, nominal width of 29 mm, and nominal heights of 1 or 2 mm, using a Fused Filament Fabrication (FFF) machine (Ultimaker 2). Then porous discs with nominal diameters of 10 mm were laser cut (LS6090, HPC Laser LTD) from the printed bars, using laser velocity and power of 25 mm/sec and 20 Watts respectively. The PLA structures were sterilised through exposure to 2.5 MRad gamma irradiation.
Thermal Bonding of AW and PLA Composite Structures
The composite structures consisted of a PLA porous disk 8 mm diameter and 1 mm thick thermally mounted to the surface of a AW disk, of the same diameter, and also 1 mm thick.
The thermal bonding process consisted of preheating, bonding and quenching phases. The AW disks were placed on a standard laboratory hot plate set to 250ºC. After a preheating phase of 120 seconds a PLA disk was then positioned, as to be concentric, on the top surface of the AW disk. The PLA was allowed to thermally adhere to the surface of the AW for 5-8 seconds before being quenched in pure ethanol. The composite structures were then set aside to allow any ethanol remaining after quenching to evaporate. The composite structures were also sterilised through exposure to 2.5 MRad gamma irradiation.
Material and Structural Characterisation Techniques
An Olympus micropublisher 5.0 RTV digital microscope, an SEM Philips XL30 ESEM-FEG and an Xradia VersaXRM-410 micro-CT were used to image samples. X-ray powder diffraction spectra were obtained from a PANalytical X'Pert Pro Multipurpose Diffractometer.
Dimensional measurements were made using Mitutoyu digital calipers. Total and open porosity levels in the AW disks were determined through weighing samples of known dimensions using a digital scale (KERN ABT 220-5DM) when dry, wet and submerged and applying Archimedes principle. Porosity levels in the PLA structures were determined through weighing samples of known external dimensions and using the density of PLA to infer the ratio of PLA to pores.
In Vitro Assays
Bone marrow-derived stromal cells (BMSCs) were isolated from adult male Sprague Dawley rats as described by Tour et al. (2014) , and used at passages 3 to 5. For all the in vitro assays, the BMSCs were seeded in triplicate for each material into 48-well plates (Corning) on the top of the sample discs (10,000 cells/disc/0.5 ml culture media/well) in a humidified atmosphere of 5% CO2 at 37°C. The experiments were repeated twice.
Cytocompatibility
The cytocompatibility was assessed by 3-(4,5-dimethythiazol-2-yl)-2,5-diphenyl tetrazolium bromide colorimetric assay (Cell Proliferation Kit I (MTT), Roche Diagnostics) or by lactate dehydrogenase (LDH) activity assay (CytoTox 96® Non-Radioactive Cytotoxicity Assay kit, in alpha-minimum essential medium supplemented with 10% foetal bovine serum and antibiotics/antimycotics (all from Life Technologies, Inc.).
Osteogenic differentiation
Alkaline phosphatase (ALP) activity was used as a marker for the osteogenic differentiation of the BMSCs in the presence of the disc samples. For the ALP assay, the normal medium was replaced with commercially available osteogenic medium (Osteogenic Differentiation -glycerophosphate, and dexamethasone.
After 7 and 14 days of the direct contact osteogenic culture, the BMSCs were washed with phosphate buffer, then lysed with 0.2% Triton X-100 (Sigma-Aldrich), and sonicated. The ALP activity was quantified by measuring the rate of formation of p-nitrophenol (pNP) produced by hydrolysis of p-nitrophenylphosphate (Sigma-Aldrich) in 1M diethanolamine solution, buffered to pH 9.8 at 37°C for 30 min using a UV/Vis spectrometer, measuring at 405 nm (Labsystems Multiskan MS). The ALP activity was normalized to the cell number correlated to LDH values, as reported previously by Allen et al. (1994) , using the CytoTox 96® Non-Radioactive ALP data were expressed as µM pNP/1000 cells. The BMSCs cultured alone on tissue culture plastic were used as controls.
In Vivo Study
The experiments were approved by the Stockholm South Ethical Committee in accordance with the policy on human care and use of laboratory animals.
In Vivo Model
Fifteen adult Sprague Dawley male rats (~350 g) were used. The rats were kept under uniform conditions for a period of least one week before commencement of the experiment. Free access to water and standard pelleted food was provided throughout the experiment. The rats were randomly divided into three groups based on the biomaterials they received: PLA discs (n=3), AW discs (n=6), and AW/PLA discs (n=6). Before implantation, the discs were washed with saline solution. A critical-size calvarial defect model was used (Tour et al., 2014) . The rats were anaesthetized by subcutaneous injection of Ketamine (Ketaminol, Intervet AB) with Xylazine (Rompun, Bayer HealthCare). During the surgery the rat was maintained on a heating was made in the sagittal plane across the cranium. The skin and underlying tissues including the periosteum and temporal muscle were detached to expose the calvarial bone. An 8-mm full thickness circular defect was created on the left parietal region using a trephine drill with a sterile saline irrigation. The disc was placed into the bone defect. The incisions were closed with single sutures in two layers.
Tissue preparation, histology and histomorphometric analysis
The rats were euthanized by CO2 inhalation at 12 weeks after surgery. The calvarial bone was surgically retrieved, and histologically processed. The samples were fixed in 4% neutralbuffered formaldehyde overnight then decalcified in 12.5% ethylenediaminetetraacetic acid, and embedded in paraffin; 5-µm serial sections were prepared parallel to the sagittal line and stained with Haematoxylin and Eosin for the assessment of the general morphology or WrightGiemsa for the assessment of local cellular inflammatory reaction. Two central sections from calvaria bone defects treated with AW or AW/PLA were assessed histomorphometrically using an image-analysis software (ImageJ, National Institutes of Health, USA) and the percentage of new bone formation was quantified. The data were statistically analyzed using the MannWhitney U-test, and significance was defined as p<0.05.
Results
Characterisation of AW, PLA, and AW/PLA Structures
For the sintered AW disks ( Figure 1 ) the total porosity was measured to be 41.85% 
In Vitro Assessment
The AW, PLA and AW/PLA discs were cyto-compatible after 24h and 48h in culture ( Figure   5a ). After both 7 and 14 days of osteogenic induction BMSCs had highest ALP activity when seeded directly onto the AW discs compared to the PLA or AW/PLA (Figure 5b ).
In Vivo Assessment
Histological assessment of the calvarial defects demonstrated that all three types of the scaffolds were biocompatible, being well integrated into the host tissues with minimal evidence of the presence of inflammatory cells (Figure 6 (a)-(c) ). For all three scaffold types the bulk of the implanted material was still present after 12 weeks.
The AW/PLA implant resulted in the largest amount of the newly formed bone, in both the AW and PLA sides of the scaffolds (Figure 6 (e) ). The newly formed bone, fibrous connective tissue and blood vessels were observed to penetrate into the AW structure (Figure 6 (d) ). No new bone formation was observed in the calvaria defects treated with the PLA alone. Figure 5 . In vitro rat BMSCs viability data (as % vs. seeded onto AW alone ± SD) after 24h
and 48h culture (a), and ALP activity data (average ± SD; µM pNP/1000 cells) after 7 days and 14 days culture (b); * P<0.05. 
Discussion
Properties and Structure
The structures achieved through FFF of PLA and binder jetting/sintering of AW were comparable in terms of porosity and morphology to those which have been previously reported (Rodrigues et al, 2016; Mancuso et al, 2017) . The novel porous-porous composite structure created by thermally bonding the two structures together offers a unique combination of mechanical properties and porosity, going beyond the range of combinations that could be achieved from a single composite material. The thermal bonding process that combines the PLA structure with the AW causes the polymer to locally melt and infiltrate into the bioceramic structure (Fig 3) , providing mechanical adhesion through physical interlocking of the materials. Throughout the in vitro testing no delamination of the PLA from the AW structures was observed, as would be expected on the basis of the slow dissolution rates of these two materials.
Cellular Assays and Osseointegration
The in vitro assays indicated that, when compared to the PLA alone, the AW material alone best supported proliferation and osteogenic differentiation of the BMSCs. The AW/PLA structure initially showed the same proliferative potential as PLA, but after 48 hours in vitro was similar to the AW. Indications of osteogenic differentiation potential increased from PLA to PLA/AW to AW. This correlates with the known biological responses of both the PLA and AW materials (Hutmacher, 2007; Narayanan, 2016; Dyson, 2007; Lee, 2015) .
The in vivo experiments broadly confirmed the in vitro results. The AW material showed excellent osseointegration with the formation of new bone, and vascularisation of the porous AW structure, both for the AW alone and when combined with the PLA. In the absence of AW, the PLA structure was well tolerated however was not osteogenic. Interestingly, the AW/PLA structures showed the largest amount of the newly formed bone in vivo, and the results indicated that the AW and PLA structures could have acted, to some extent, synergistically:
the presence of the osteoinductive AW structure appears to have stimulated significant bone growth in the larger pores of the adjacent PLA structure. The exact mechanisms for this are difficult to define: the AW and PLA degradation products might play an important role in tuning the local inflammatory reaction and stimulating osteogenic differentiation of progenitor cells (Williams, 1992; Middleton and Tipton, 2000) .
A key concern with layered composite structures is delamination, and no delamination was observed in any of the composite structures, although no loading was applied. In fact the degree of osseointegration of the composite structure in Figure 6 (c) indicates delamination is unlikely as the structure is effectively bound together by the new bone which has grown into and around the structure. Clearly the structure is only held together by new bone once that bone has formed, and so for immediate stability the bond between the materials needs to have an appropriate inherent strength. With materials which resorbed quicker or did not have the same degree of osseointegration it is considered that the risk of delamination would be much higher.
Implications for Bone Implant Design
The results offer two key observations for bone implant design based on macro-scale composite structures. Firstly, that it is possible through biocomposites fabricated at a macroscale to develop implants which provide a match to both cortical and cancellous bone properties. Secondly that to avoid delamination in such structures an appropriate choice of materials and structures can both avoid immediate resorption and promote osseointegration.
The mechanical properties of the two phases of the composite are such that the composites could be exploited for implants to treat defects which were of a size which required mechanical support. Clearly an appropriate fixation scheme would be required, but if properly fixed the implants could be immediately load bearing. To improve the composite structures, particularly for larger implants it would be preferable to further enhance the osseoinductivity of the PLA structure. This could be achieved through making the structure from a micro-scale composite of PLA and a bioceramic (nano-or micro-HA, for instance (Tayton et al; 2014) , or AW) or through surface functionalisation (with collagen or gelatin for example; Haaparanta et al., 2014) . PLA based materials have also been shown to offer utility for drug release (Saini et al., 2016) , and so further enhancement of bioactivity could be achieved through incorporating specific molecules into the polymer, with the proviso that any effects on the mechanical properties would have to be carefully monitored.
Conclusions
A novel AW/PLA composite structure, which matches cortical and cancellous bone properties over millimetre length scales has been produced. In vitro tests on the composite structure indicated proliferative and osseoinductive properties in between those of AW and PLA alone, but in vivo the combination of the AW and PLA structures supported significant new bone growth. The use of materials which are initially effectively bonded, which do not resorb over short timescales, and which promote significant bone ingrowth is considered an effective strategy to minimise delamination of layer composites in vivo.
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